Phase III trial to enroll 420 men across up to 10 clinical sites in Canada -- First patient has now been dosed in the Company's Phase III trial evaluating TH07 -- TH07 is a patented prescription ...

The findings, shared at the annual American Academy of Dermatology conference, have dermatologists excited.

If you’ve started to notice the early signs of hair loss, it’s easy to wonder what’s causing you to shed hair. Telogen effluvium and androgenetic alopecia are two common forms of hair loss. One causes ...

Some women may shed more than men, but this depends on genetics, stress levels, hormonal changes, styling preferences, and health status. Research shows that men are more likely to experience genetic ...

If you’re reading this because you’re losing your hair, you’re not alone — hair loss is a common issue affecting more than half of men by the time they’re in their forties. The most common type of ...

Pharmacists play a role in advising patients with hair loss about self-management and proper application of over the counter products. There are several types of hair loss, but androgenetic alopecia, ...

Please provide your email address to receive an email when new articles are posted on . 81% of surveyed prescribers were in support of using oral minoxidil to treat androgenetic alopecia. Prescribers ...

Absci Corporation downgraded to Hold as ABS-101 stalls and focus shifts to ABS-201; cash runway to H1 2028, but risks persist ...

Researchers at the San Carlos Clinical Hospital in Madrid may have targeted a potential solution for hair loss. A recent study analyzed the effect of injecting mice's skin with stem cells from human ...

Add Yahoo as a preferred source to see more of our stories on Google. Noticed more strands in your hair brush or shower drain lately? Or maybe you've spotted sparse spots on your scalp. Unfortunately, ...